Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Completed 131Recruiting 55Terminated 46Active not recruiting 32Unknown 19Withdrawn 9Not yet recruiting 6Available 3Suspended 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 7Genitourinary 2Gastrointestinal 2Dermatologic 2Breast 2NET 1Lymphoid 1Gynecologic 1Endocrine 1

Conditions

Colorectal Neoplasms 27Pancreatic Neoplasms 16Stomach Neoplasms 13Carcinoma, Hepatocellular 12Breast Neoplasms 8Rectal Neoplasms 7Neoplasms 7Esophageal Neoplasms 7Colonic Neoplasms 7Prostatic Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Ovarian Neoplasms 3Neoplasm Metastasis 3Lung Neoplasms 3Endometrial Neoplasms 3Diabetes Mellitus 3Crohn Disease 3Cholangiocarcinoma 3Carcinoma, Renal Cell 3Bile Duct Neoplasms 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Sarcoma 2Peritoneal Neoplasms 2Multiple Sclerosis 2Multiple Myeloma 2Melanoma 2Liver Neoplasms 2Irritable Bowel Syndrome 2Head and Neck Neoplasms 2

Interventions

tivozanib 1atezolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × Sarcoma × Gastrointestinal × Clear all
NCT05000294 2026-02-18

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types

University of Florida

Phase 1/2 Suspended
29 enrolled
BreastEndocrineGastrointestinalGenitourinaryGynecologicNETSarcoma

Bile Duct Neoplasms, Breast Neoplasms, Gallbladder Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Vulvar Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT04714983 2024-04-09

DNX-2440 for Resectable Colorectal Liver Metastasis

DNAtrix, Inc.

Phase 1 Suspended
30 enrolled
BreastDermatologicGastrointestinalGenitourinarySarcoma

Breast Neoplasms, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Melanoma, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡